NRx Pharmaceuticals (NRXP) News Today $2.69 +0.05 (+1.89%) Closing price 04:00 PM EasternExtended Trading$2.78 +0.09 (+3.16%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRXP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period NRx Pharmaceuticals price target raised to $25 from $21 at BTIGAugust 25 at 11:48 AM | msn.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2025 Earnings Call TranscriptAugust 21, 2025 | msn.comNRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call TranscriptAugust 20, 2025 | seekingalpha.comNRx Pharmaceuticals (NASDAQ:NRXP) Given Buy Rating at D. Boral CapitalAugust 20, 2025 | americanbankingnews.comAdvancements on Multiple Fronts in $3 Billion Suicidal Depression Market, Highlighted by FDA Fast Track Designation for Effective NRX 100 Drug Therapy: NRx Pharmaceuticals, Inc ...August 19, 2025 | theglobeandmail.comNRx Pharmaceuticals (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead ProgramsAugust 19, 2025 | msn.comNrx Pharmaceuticals Faces Financing Hurdles in Strategic Acquisitions of Kadima and Dura MedicalAugust 19, 2025 | msn.comNRX Pharmaceuticals Inc (NRXP) Q2 2025 Earnings Report Preview: What to ExpectAugust 19, 2025 | finance.yahoo.comNRx Pharmaceuticals sees cash runway into 2026August 18, 2025 | msn.comWhat To Expect From NRX Pharmaceuticals Inc (NRXP) Q2 2025 EarningsAugust 18, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and ...August 18, 2025 | gurufocus.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and ...August 18, 2025 | gurufocus.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 18, 2025 | globenewswire.comNRX Pharmaceuticals Gains FDA Fast Track for NRX-100August 16, 2025 | msn.comInsights Ahead: NRX Pharmaceuticals's Quarterly EarningsAugust 14, 2025 | benzinga.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results ...August 13, 2025 | gurufocus.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025August 13, 2025 | prnewswire.comNRx Pharmaceuticals to Report Q2 2025 Results on August 14August 13, 2025 | msn.comNew to The Street Client NRx Pharmaceuticals Secures FDA Fast Track Designation for NRX-100, Expanding Reach to 13 Million Americans Confronting Suicidal IdeationAugust 11, 2025 | finanznachrichten.deNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025August 11, 2025 | globenewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar DepressionAugust 11, 2025 | prnewswire.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency ...August 8, 2025 | finance.yahoo.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)August 8, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine ...August 6, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine ProductsAugust 4, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025July 29, 2025 | prnewswire.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Charts Dual-Path for NRX-100July 21, 2025 | finance.yahoo.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen TreatmentJuly 17, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Given Average Rating of "Buy" by BrokeragesJuly 11, 2025 | marketbeat.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry ClinicJuly 9, 2025 | finance.yahoo.comNRx Pharmaceuticals (NASDAQ:NRXP) Stock Price Down 0.3% - Here's What HappenedJuly 8, 2025 | marketbeat.comNRX Pharmaceuticals Inc Ordinary Shares NRXP - MorningstarJuly 3, 2025 | morningstar.comMNRx Pharmaceuticals (NASDAQ: NRXP) Applies for FDA Commissioner's National Priority Voucher for IV Ketamine NRX-100 - BenzingaJuly 2, 2025 | benzinga.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Applies for FDA Commissioner's National Priority Voucher for IV Ketamine NRX-100June 30, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NRXP) - Yahoo FinanceJune 27, 2025 | finance.yahoo.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional ...June 27, 2025 | nasdaq.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry ClinicJune 27, 2025 | finance.yahoo.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry ClinicsJune 26, 2025 | prnewswire.comNRX Pharmaceuticals Inc News (NRXP) - Investing.comJune 24, 2025 | investing.comIBN Initiates Coverage of NRx Pharmaceuticals Inc.June 24, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)June 23, 2025 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) Receives "Buy" Rating from D. Boral CapitalJune 20, 2025 | marketbeat.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr PartnersJune 17, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. ...June 16, 2025 | gurufocus.comNRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partnersJune 16, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Average Rating of "Buy" from BrokeragesJune 16, 2025 | marketbeat.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid ConferenceJune 12, 2025 | prnewswire.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic NetworkJune 6, 2025 | finance.yahoo.comNRx Pharmaceuticals' (NRXP) "Buy" Rating Reaffirmed at D. Boral CapitalJune 6, 2025 | marketbeat.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV KetamineJune 5, 2025 | finance.yahoo.com Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address NRXP Media Mentions By Week NRXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXP News Sentiment▼-0.130.70▲Average Medical News Sentiment NRXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXP Articles This Week▼93▲NRXP Articles Average Week Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GENFIT News MediWound News Rapt Therapeutics News Organigram Global News Eupraxia Pharmaceuticals News Korro Bio News Tenaya Therapeutics News enGene News Instil Bio News China SXT Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXP) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access